Found: 6
Select item for more details and to access through your institution.
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.663517
- By:
- Publication type:
- Article
Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10608-9
- By:
- Publication type:
- Article
Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10608-9
- By:
- Publication type:
- Article
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3511, doi. 10.1007/s00432-022-04248-y
- By:
- Publication type:
- Article
DHA attenuates CAR-T cell efficacy through aggravating exhaustion and inducing apoptosis.
- Published in:
- Biologia, 2023, v. 78, n. 4, p. 1141, doi. 10.1007/s11756-023-01326-5
- By:
- Publication type:
- Article